Anorectal malignant melanoma: A clinicopathologic study, including immunohistochemistry and DNA flow cytometry

Cancer

Volumn 79, Issue 1, 1997, Pages 18-25

  Ben Izhak, Ofer ^a,b   Levy, Rivka ^a,b   Weill, Shoshana ^c   Groisman, Gabriel ^d   Cohen, Hector ^e   Stajerman, Selina ^f   Misselevich, Ines ^g   Nitecky, Sami ^a   Eidelman, Shmuel ^a,b   Kerner, Hedviga ^a,b  

^a RAMBAM MEDICAL CENTER   (Israel)

^b TECHNION ISRAEL INSTITUTE OF TECHNOLOGY   (Israel)

^c CARMEL MEDICAL CENTER   (Israel)

^d HILLEL YAFFE MEDICAL CENTER   (Israel)

^e WESTERN GALILEE HOSPITAL   (Israel)

^f Rebecca Sieff Government Hospital   (Israel)

^g BNAI ZION MEDICAL CENTER   (Israel)

Author keywords

anal canal; carcinoembroyonic antigen; cytokeratin; DNA ploidy; epithelial membrane antigen; flow cytometry; malignant melanoma; rectum

Indexed keywords

CARCINOEMBRYONIC ANTIGEN; CROSS REACTING ANTIGEN; CYTOKERATIN; EPITHELIAL MEMBRANE ANTIGEN; MONOCLONAL ANTIBODY B.72.3; MONOCLONAL ANTIBODY HMB 45; PROTEIN S 100; VIMENTIN;

ADULT; AGED; ANEUPLOIDY; ANUS CANCER; ARAB; ARTICLE; CLINICAL ARTICLE; FEMALE; FLOW CYTOMETRY; HUMAN; HUMAN TISSUE; JEW; MALE; MELANOMA; PRIORITY JOURNAL; PROGNOSIS; TUMOR LOCALIZATION;

ADULT; AGED; ANUS NEOPLASMS; DNA, NEOPLASM; FEMALE; FLOW CYTOMETRY; HUMANS; MALE; MELANOMA; MIDDLE AGED; RECTAL NEOPLASMS; TUMOR MARKERS, BIOLOGICAL;

EID: 0031028243     PISSN: 0008543X     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0142(19970101)79:1<18::AID-CNCR4>3.0.CO;2-I     Document Type: Article

References (40)

1. Wanebo HJ, Woodruff JM, Farr GH, Quan SH. Anorectal melanoma. Cancer 1981;47:1891-900.
2. Mills SE, Cooper PH. Malignant melanoma of the digestive system. Pathol Annu 1983;18:1-26.
3. Goldman S, Glimelius B, Pahlman L. Anorectal malignant melanoma in Sweden: report of 49 patients. Dis Colon Rectum 1990;33:874-7.
4. Helwig EB. Neoplasms of the anus. In: Norris HT, editor. Pathology of the colon, small intestine, and anus. 2nd edition. New York: Churchill-Livingstone, 1991:381-3.
5. Weinstock MA. Epidemiology and prognosis of anorectal melanoma. Gastroenterology 1993;104:174-8.
6. Longo WE, Vernava AM III, Wade TP, Coplin MA, Virgo KS, Johnson FE. Rare anal canal cancers in the U.S. veteran: patterns of disease and results of treatment. Am Surg 1995;61:495-500.
7. Bishop PW, Menasce LP, Yates AJ, Win NA, Banerjee SS. An immunophenotypic survey of malignant melanomas. Histopathology 1993;23:159-66.
8. Ben-Izhak O, Stark P, Levy R, Bergman R, Lichtig C. Epithelial markers in malignant melanoma: a study of primary lesions and their metastases. Am J Dermatopathol 1994; 16:241-6.
9. Bartkowiak D, Schumann J, Otto FJ, Lippold A, Drepper H. DNA flow cytometry in the prognosis of primary malignant melanoma. Oncology 1991;48:39-43.
10. Gattuso P, Reddy V, Solans E, Kathuria S, Aranha GV, Jacobs HK, et al. Is DNA ploidy of prognostic significance in stage I cutaneous melanoma? [discussion] Surgery 1990;108:702-8. Discussion on: Surgery 1990;108:708-9.
11. Gattuso P, Reddy V, Solans E, Kathuria S, Aranha GV, Jacobs HK, et al. Is DNA ploidy of prognostic significance in stage I cutaneous melanoma? [discussion] Surgery 1990;108:702-8. Discussion on: Surgery 1990;108:708-9.
12. Coleman K, Baak JPA, van Diest PJ, Curran B, Mullaney J, Fenton M, et al. DNA ploidy status in 84 ocular melanomas: a study of DNA quantitation in ocular melanomas by flow cytometry and automatic and interactive static image analysis. Hum Pathol 1995;26:99-105.
13. Scheistroen M, Trope C, Koem J, Pettersen EO, Abeler V, Kristensen GB. Malignant melanoma of the vulva: evaluation of prognostic factors with emphasis on DNA ploidy in 75 patients. Cancer 1995;75:72-80.
14. Franquemont DW, Mills SE. Sinonasal malignant melanoma: a clinicopathologic and immunohistochemical study of 14 cases. Am J Clin Pathol 1991;96:689-97.
15. Ben-Izhak O, Lichtig C. CEA reactivity in amelanotic malignant melanoma of the anal canal [discussion]. Pathol Res Pract 1993;189:1071-6. Discussion on: Pathol Res Pract 1993;189:1077-83.
16. Ben-Izhak O, Lichtig C. CEA reactivity in amelanotic malignant melanoma of the anal canal [discussion]. Pathol Res Pract 1993;189:1071-6. Discussion on: Pathol Res Pract 1993;189:1077-83.
17. Ben-Izhak O, Groisman GM. Anal malignant melanoma and soft-tissue malignant fibrous histiocytoma in neurofibromatosis type 1. Arch Pathol Lab Med 1995;119:285-8.
18. Hedley DW, Friedlander ML, Taylor IW, Rugg CA, Musgrove EA. Method for analysis of cellular DNA content of paraffin-embedded pathological material using flow cytochemistry. J Histochem Cytochem 1983;31:1333-5.
19. Shankey TV, Rabinovitch PS, Bagwell B, Baver KD, Duque RE, Hedley DW, et al. Guidelines for implementation of clinical DNA cytometry. International Society for Analytical Cytology. Cytometry 1993;14:472-7.
20. Slingluff CL Jr., Vollmer RT, Seigler HF. Anorectal melanoma: clinical characteristics and results of surgical management in twenty-four patients. Surgery 1990;107:1-9.
21. Cooper PH, Mills SE, Allen MS Jr. Malignant melanoma of the anus: report of 12 patients and analysis of 255 additional cases. Dis Colon Rectum 1982;25:693-703.
22. Cohen D, Siegal B, Jacob ET. Anorectal melanomas in Israel [in Hebrew]. Harefuah 1983;105:3-4.
23. Brady MS, Kavolius JP, Quan SHQ. Anorectal melanoma: a 64-year experience at Memorial Sloan-Kettering Cancer Center. Dis Colon Rectum 1995;38:146-51.
24. Ross M, Pezzi C, Pezzi T, Meurer D, Hickey R, Balch C. Patterns of failure in anorectal melanoma: a guide to surgical therapy. Arch Surg 1990;125:313-6.
25. Konstadoulakis MM, Ricaniadis N, Walsh D, Karakousis CP. Malignant melanoma of the anorectal region. J Surg Oncol 1995;58:118-20.
26. Antoniuk PM, Tjandra JJ, Webb BW, Petras RE, Milsom JW, Fazio VW. Anorectal malignant melanoma has a poor prognosis. Int J Colorectal Dis 1993;8:81-6.
27. Kantarovsky A, Kaufman Z, Zager M, Lew S, Dinbar A. Anorectal region malignant melanoma. J Surg Oncol 1988;38:77-9.
28. Rogers GT. Carcinoembryonic antigens and related glycoproteins: molecular aspects and specificity. Biochim Biophys Acta 1983;695:227-49.
29. Harwood PJ, Britton DW, Southall PJ, Boxer GM, Rawlins G, Rogers GT. Mapping epitope characteristics on carcinoembryonic antigen. Br J Cancer 1986;54:75-82.
30. Selby WL, Nance KV, Park HKL. CEA immunoreactivity in metastatic malignant melanoma. Mod Pathol 1992;5:415-9.
31. Sheahan K, O'Brien MJ, Burke B, Dervan P, O'Keane JC, Gottlieb LS, et al. Differential reactivities of carcinoembryonic antigen (CEA) and CEA-related monoclonal and polyclonal antibodies in common epithelial malignancies. Am J Clin Pathol 1990;94:157-64.
32. Miettinen M, Franssila K. Immunohistochemical spectrum of malignant melanoma: the common presence of keratins. Lab Invest 1989;61:623-8.
33. Zarbo RJ, Gown AM, Nagle RB, Visscher DW, Crissman JD. Anomalous cytokeratin expression in malignant melanoma: one-and two-dimensional western blot analysis and immunohistochemical survey of 100 melanomas. Mod Pathol 1990;3:494-501.
34. Allen BC, Herrera GA. Phenotypic cytoskeletal heterogeneity in melanoma, a challenge to the surgical pathologist evaluating a poorly differentiated neoplasm: an illustrative case. Ultrastruct Pathol 1991;15:87-97.
35. Cosgrove MM, Rich KA, Martin SE. Keratin intermediate filament expression in malignant melanoma [abstract]. Mod Pathol 1991;4:28A.
36. Azumi N, Battifora H. The distribution of vimentin and keratin in epithelial and nonepithelial neoplasms: a comprehensive immunohistochemical study on formalin-and alcohol-fixed tumors. Am J Clin Pathol 1987;88:286-96.
37. Herrera GA, Turbat-Herrera EA, Lott RL. S-100 protein expression by primary and metastatic adenocarcinomas. Am J Clin Pathol 1988;89:168-76.
38. Hancock C, Allen BC, Herrera GA. HMB-45 detection in adenocarcinomas. Arch Pathol Lab Med 1991;115:886-90.
39. Ordonez NG, Ji XL, Hickey RC. Comparison of HMB-45 monoclonal antibody and S-100 protein in the immunohistochemical diagnosis of melanoma. Am J Clin Pathol 1988; 90:385-90.
40. Silver HKB, Karim KA, Le Riche J, de Jong G, Spinelli J, Worth A, et al. Nuclear DNA, serum sialic acid and measured depth in malignant melanoma for predicting disease recurrence and survival. Int J Cancer 1989;44:31-4.